Soto-Fajardo C

Language: Spanish
References: 6
Page: 36-37
PDF size: 167.54 Kb.

REFERENCES

1. Roman YM. Moving the needle in gout management: the role of culture, diet, genetics, and personalized patient care practices. Nutrients. 2022; 14 (17): 3590. Available from: https://www.mdpi.com/2072-6643/14/17/3590

2. Dehlin M, Jacobsson L, Roddy E. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol. 2020; 16 (7): 380-390. doi: 10.1038/s41584-020-0441-1

3. Terslev L, Gutierrez M, Christensen R, Balint PV, Bruyn GA, Delle Sedie A et al. Assessing elementary lesions in gout by ultrasound: results of an OMERACT patient-based agreement and reliability exercise. J Rheumatol. 2015; 42 (11): 2149-2154. Available from: http://www.jrheum.org/lookup/doi/10.3899/jrheum.150366

4. Fukuda T, Subramanian M, Noda K, Kumeta S, Mori H, Ikeda N et al. The comprehensive role of dual-energy CT in gout as an advanced diagnostic innovation. Skeletal Radiol. 2024. doi: 10.1007/s00256-024-04856-4. Available in: https://link.springer.com/article/10.1007/s00256-024-04856-4

5. Zhang X, Liu J. Regulating lipid metabolism in gout: A new perspective with therapeutic potential. Int J Gen Med. 2024; 17: 5203-5217. doi: 10.2147/IJGM.S499413. Available from: https://www.dovepress.com/regulating-lipid-metabolism-in-gout-a-new-perspective-with-therapeutic-peer-reviewed-fulltext-article-IJGM

6. Abdel Mageed SS, Elimam H, Elesawy AE, Abulsoud AI, Raouf AA, Tabaa MME et al. Unraveling the impact of miRNAs on gouty arthritis: diagnostic significance and therapeutic opportunities. Naunyn Schmiedebergs Arch Pharmacol. 2025; 398 (4): 3433-3450. doi: 10.1007/s00210-024-03603-9